99 related articles for article (PubMed ID: 36427327)
21. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
[TBL] [Abstract][Full Text] [Related]
22. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
[TBL] [Abstract][Full Text] [Related]
23. Comparison of conventional Pap smear and liquid-based cytology: A study of cervical cancer screening at a tertiary care center in Bihar.
Pankaj S; Nazneen S; Kumari S; Kumari A; Kumari A; Kumari J; Choudhary V; Kumar S
Indian J Cancer; 2018; 55(1):80-83. PubMed ID: 30147099
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Cervical Smears Performed by General Practitioners on the Cervical Cancer Screening Rate of their Female Patients: A Claim Database Analysis and Cross-Sectional Survey.
Favre J; Rochoy M; Raginel T; Pelletier M; Messaadi N; Deken-Delannoy V; Duhamel A; Berkhout C
J Womens Health (Larchmt); 2018 Jul; 27(7):933-938. PubMed ID: 29583084
[TBL] [Abstract][Full Text] [Related]
25. Effect of health education about cervical cancer and papanicolaou testing on the behavior, knowledge, and beliefs of Turkish women.
Bebis H; Reis N; Yavan T; Bayrak D; Unal A; Bodur S
Int J Gynecol Cancer; 2012 Oct; 22(8):1407-12. PubMed ID: 22932261
[TBL] [Abstract][Full Text] [Related]
26. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
27. False-Negative Rate of Papanicolaou Testing: A National Survey from the Thai Society of Cytology.
Koonmee S; Bychkov A; Shuangshoti S; Bhummichitra K; Himakhun W; Karalak A; Rangdaeng S
Acta Cytol; 2017; 61(6):434-440. PubMed ID: 28738387
[TBL] [Abstract][Full Text] [Related]
28. Patterns and correlates of cervical cancer screening initiation in a large integrated health care system.
Becerra-Culqui TA; Lonky NM; Chen Q; Chao CR
Am J Obstet Gynecol; 2018 Apr; 218(4):429.e1-429.e9. PubMed ID: 29277629
[TBL] [Abstract][Full Text] [Related]
29. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995.
Lawson HW; Lee NC; Thames SF; Henson R; Miller DS
Obstet Gynecol; 1998 Nov; 92(5):745-52. PubMed ID: 9794662
[TBL] [Abstract][Full Text] [Related]
30. Compliance with cervical cancer screening and human papillomavirus testing guidelines among insured young women.
Hirth JM; Tan A; Wilkinson GS; Berenson AB
Am J Obstet Gynecol; 2013 Sep; 209(3):200.e1-7. PubMed ID: 23727519
[TBL] [Abstract][Full Text] [Related]
31. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
32. Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution.
Kang M; Ha SY; Cho HY; Chung DH; Kim NR; An J; Lee S; Seok JY; Jeong J
J Pathol Transl Med; 2020 Jan; 54(1):112-118. PubMed ID: 31964113
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer screening practices, knowledge of screening and risk, and highly active antiretroviral therapy adherence among women living with human immunodeficiency virus in Lima, Peru.
Delgado JR; Menacho L; Segura ER; Roman F; Cabello R
Int J STD AIDS; 2017 Mar; 28(3):290-293. PubMed ID: 27789849
[TBL] [Abstract][Full Text] [Related]
34. Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan.
Su CH; Hsu PS; Lin CS
BMC Health Serv Res; 2023 Aug; 23(1):878. PubMed ID: 37605162
[TBL] [Abstract][Full Text] [Related]
35. Does gel affect cytology or comfort in the screening papanicolaou smear?
Gilson M; Desai A; Cardoza-Favarato G; Vroman P; Thornton JA
J Am Board Fam Med; 2006; 19(4):340-4. PubMed ID: 16809647
[TBL] [Abstract][Full Text] [Related]
36. Inadequate screening in patients evaluated by nongynecologists for cervical cancer: a case control analysis.
Cole ME; Milam MR; Scott TA; Jones HW
Am J Obstet Gynecol; 2008 May; 198(5):e48-50. PubMed ID: 18342826
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Papanicolaou test with visual detection tests in screening for cervical cancer and developing the optimal strategy for low resource settings.
Aggarwal P; Batra S; Gandhi G; Zutshi V
Int J Gynecol Cancer; 2010 Jul; 20(5):862-8. PubMed ID: 20606535
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.
Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP
Am J Obstet Gynecol; 2017 Feb; 216(2):151.e1-151.e9. PubMed ID: 27746152
[TBL] [Abstract][Full Text] [Related]
39. Cervical cancer screening in Santiago Atitlán, Guatemala.
Frey MK; Roselli N; Gertz E; Cuc JC; Boyd L; Shirazian T
Int J Gynaecol Obstet; 2016 Oct; 135(1):119. PubMed ID: 27451397
[No Abstract] [Full Text] [Related]
40. Prevalence of Abnormal Cervical Cytology in HIVNegative Women Participating in a Cervical Cancer Screening Program in Calmette Hospital, Cambodia.
Hav M; Eav S; Heang N; Pich P; Lim D; Leang V; Korn A; Lay S; Pluot M; Kruy L
Asian Pac J Cancer Prev; 2016; 17(7):3101-3. PubMed ID: 27509936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
